4-hydroxycyclophosphamide has been researched along with Leukemia P388 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Voelcker, G | 1 |
| Bielicki, L; Hohorst, HJ; Voelcker, G | 1 |
| Kooistra, KL; Powis, G; Rosenow, S; Van Dyke, RA | 1 |
3 other study(ies) available for 4-hydroxycyclophosphamide and Leukemia P388
| Article | Year |
|---|---|
Causes and possibilities to circumvent cyclophosphamide toxicity.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Proliferation; Cyclophosphamide; Female; Leukemia P388; Male; Mice; Phosphoramide Mustards; Toxicity Tests | 2020 |
Thiazolidinyl- and perhydrothiazinylphosphamidesters: toxicity and preliminary antitumour evaluation.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Injections, Intraperitoneal; Leukemia P388; Male; Mast-Cell Sarcoma; Mice; Nitrogen Mustard Compounds; Prodrugs; Protein Binding; Thiazines; Thiazoles; Thiazolidines; Tissue Distribution | 1997 |
Increased toxicity of the antitumor drug cyclophosphamide in mice in the presence of the volatile anesthetic agent halothane.
Topics: Animals; Brain; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Halothane; Kidney Diseases; Lethal Dose 50; Leukemia P388; Male; Metabolic Clearance Rate; Mice; Urinary Bladder Diseases | 1986 |